Antibody Blockade of Integrin Alpha-V-Beta-6 (avb6) as a Novel Treatment for NSCLC
View/ Open
Published version
Embargoed until: 2222-01-01
Reason: Published version - Permanent embargo
Embargoed until: 2222-01-01
Reason: Published version - Permanent embargo
Volume
13
Pagination
S518 - S519
DOI
10.1016/j.jtho.2018.08.700
Issue
ISSN
1556-0864